e-learning
resources
Munich 2014
Sunday, 07.09.2014
COPD exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Endoplasmic reticulum stress in bronchial tissue in patients with COPD and lung cancer
B. Nunez, S. Scrimini, A. Agustí, A. Iglesias, B. Cosio, M. Lopez, A. Rios, J. A. Torrecilla, J. Sauleda (Palma de Mallorca, Barcelona, Spain)
Source:
International Congress 2014 – COPD exacerbations
Session:
COPD exacerbations
Session type:
Poster Discussion
Number:
522
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Nunez, S. Scrimini, A. Agustí, A. Iglesias, B. Cosio, M. Lopez, A. Rios, J. A. Torrecilla, J. Sauleda (Palma de Mallorca, Barcelona, Spain). Endoplasmic reticulum stress in bronchial tissue in patients with COPD and lung cancer. Eur Respir J 2014; 44: Suppl. 58, 522
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Endoplasmic reticulum stress, COPD and lung cancer
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Prevalence of COPD and emphysema at the time of diagnosis of primary lung cancer
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Increased sirtuin expression in patient with lung squamous cell carcinoma co-morbid with COPD
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Prognostic affect of the chronic obstructive pulmonary disease on the local-advanced stage non-small cell lung cancer
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
COPD and lung cancer: Prevalence, infradiagnosis, phenotypes and multidimensional characterization
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016
The impact of chronic obstructive pulmonary disease on survival of the patients with small-cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Incidence of lung cancer in smokers with and without COPD: Observational study
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Lung cancer in COPD patients on home oxygen-therapy
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016
Psychological assessment in COPD and lung cancer patients in pulmonary rehabilitation
Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity
Year: 2015
Osteopontin levels in sputum supernatant and serum of patients with lung cancer: Does coexistent COPD make the difference?
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Advanced lung cancer inflammation index (ALI): A new pronostic score in patients with non small cell lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
Lung cancer in patient with chronic obstructive pulmonary disease (comorbidity by smokers-a cumulative effect of exogenic and endogenic factors? Part II)
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Lung cancer screening in COPD patients: NLST criteria vs a COPD screening score
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
COPD; IPF; lung cancer in same individual: Can it be called 'AJMERITES SYNDROME?
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
The association of lung cancer with active pulmonary tuberculosis.
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014
Chronic obstructive pulmonary disease as a predictor of lung cancer mortality
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Stereotactic body radiation does not impair respiratory health in patients with stage I non-small cell lung cancer
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
Lung volume reduction effect after lobectomy in COPD patients
Source: Annual Congress 2013 –Lung surgery: preoperative assessment and postoperative outcome
Year: 2013
Lung function in the elderly patients with a diagnosis of lung cancer - A challenge for the surgical treatment?
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept